{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:05:05Z","timestamp":1793185505116,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ajog.2010.07.037","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T10:47:13Z","timestamp":1286794033000},"page":"547.e1-547.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"title":["Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis"],"prefix":"10.1016","volume":"203","author":[{"given":"Ioannis D.","family":"Gallos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet","family":"Shehmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalis K.","family":"Papapostolou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janesh K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2010.07.037_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia: a long-term study of \u201duntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2010.07.037_bib2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group Study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2010.07.037_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of Levonorgestrel In women using a Levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2010.07.037_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (MINORS): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ajog.2010.07.037_bib5","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Proceedings of the Third Symposium on Systematic Reviews. Beyond The Basics: Improving Quality And Impact, 2000."},{"key":"10.1016\/j.ajog.2010.07.037_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Dersimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2010.07.037_bib7","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.322.7300.1479","article-title":"Forest plots: trying to see the wood and the trees","volume":"322","author":"Lewis","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2010.07.037_bib8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2010.07.037_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/ijgc-00009577-200603000-00055","article-title":"The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia","volume":"16","author":"Bese","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2010.07.037_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1479-828X.2009.00981.x","article-title":"The effect of the Levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review","volume":"49","author":"Buttini","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2010.07.037_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejogrb.2005.09.004","article-title":"The management of endometrial hyperplasia: an evaluation of current practice","volume":"125","author":"Clark","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2010.07.037_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s004040000154","article-title":"Metabolic effects associated with high-dose continuous Megestrol acetate administration in the treatment of endometrial pathology","volume":"265","author":"Guven","year":"2001","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2010.07.037_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/gme.0b013e3181659837","article-title":"Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a Levonorgestrel intrauterine device","volume":"15","author":"Haimovich","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2010.07.037_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ijgc-00009577-200403000-00023","article-title":"Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment","volume":"14","author":"Horn","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2010.07.037_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000084142","article-title":"Treatment of non-atypic endometrial hyperplasia using thermal balloon endometrial ablation therapy","volume":"59","author":"Jarvela","year":"2005","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2010.07.037_bib16","first-page":"365","article-title":"Treatment for complex atypical hyperplasia of the endometrium","volume":"22","author":"Jobo","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ajog.2010.07.037_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome","volume":"167","author":"Kaku","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajog.2010.07.037_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ijgc-00009577-200801000-00024","article-title":"Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of Rapamycin are associated with progesterone refractory endometrial hyperplasia","volume":"18","author":"Milam","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2010.07.037_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2006.06.013","article-title":"Combined Phospho-AKT and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage IA, G1 adenocarcinoma of the endometrium","volume":"248","author":"Minaguchi","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajog.2010.07.037_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2010.07.037_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1447-0756.2005.00253.x","article-title":"Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study","volume":"31","author":"Rattanachaiyanont","year":"2005","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2010.07.037_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/AOG.0b013e318198a10a","article-title":"Progestin therapy of complex endometrial hyperplasia with and without atypia","volume":"113","author":"Reed","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2010.07.037_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1471-0528.2008.02024.x","article-title":"Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases","volume":"116","author":"Signorelli","year":"2009","journal-title":"BJOG"},{"issue":"Suppl 9","key":"10.1016\/j.ajog.2010.07.037_bib24","first-page":"93","article-title":"Conservative management of atypical endometrial hyperplasia and early invasive carcinoma with intrauterine Levonorgestrel: a progesterone receptor study","volume":"9","author":"Tjalma","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2010.07.037_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2008.02.022","article-title":"The effectiveness of a Levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia\u2014a long-term follow-up study","volume":"139","author":"Varma","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2010.07.037_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ygyno.2005.10.030","article-title":"Effect of Levonorgestrel IUD and oral Medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha AND ER-beta) in human endometrial hyperplasia","volume":"101","author":"Vereide","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2010.07.037_bib27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2010.07.037_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.maturitas.2006.12.004","article-title":"Management of patients with non-atypical and atypical endometrial hyperplasia with a Levonorgestrel-releasing intrauterine system: long-term follow-up","volume":"57","author":"Wildemeersch","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2010.07.037_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humpath.2009.06.012","article-title":"Increased natural killer cells and decreased regulatory t cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"41","author":"Witkiewicz","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2010.07.037_bib30","first-page":"143","article-title":"Comparison of two therapies in simple endometrial hyperplasia: oral Medroxyprogesterone acetate versus depot GNRH agonist","volume":"11","author":"Yener","year":"1997","journal-title":"Jinekoloji Obstet Dergisi"},{"key":"10.1016\/j.ajog.2010.07.037_bib31","first-page":"242","article-title":"[Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women]","volume":"41","author":"Yu","year":"2006","journal-title":"Chung-Hua Fu Chan Ko Tsa Chih [Chinese J Obstet Gynecol]"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781000921X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781000921X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:39:59Z","timestamp":1757587199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293781000921X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S000293781000921X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2010.07.037","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2010.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}